Filtered By:
Specialty: Cardiology
Condition: Patent Foramen Ovale
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 614 results found since Jan 2013.
Cost Effectiveness of Percutaneous Closure Versus Medical Therapy for Cryptogenic Stroke in Patients With a Patent Foramen Ovale
In patients with patent foramen ovales (PFOs) and cryptogenic stroke, observational studies have demonstrated reductions in recurrent neurologic events with transcatheter PFO closure compared with medical therapy. Randomized controlled trials and meta-analyses have shown a trend toward benefit with device closure. The cost-effectiveness of PFO closure has not been described. Therefore, a detailed cost analysis was performed using pooled weighted outcome and complication rates from published randomized controlled trials, Medicare cost tables, and wholesale medication prices.
Source: The American Journal of Cardiology - September 4, 2014 Category: Cardiology Authors: Christopher A. Pickett, Todd C. Villines, Michael A. Ferguson, Edward A. Hulten Tags: Miscellaneous Source Type: research
Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure
This study aims to compare long-term outcomes of PFO closure versus non-closure.
Source: International Journal of Cardiology - May 20, 2015 Category: Cardiology Authors: Naqibullah Mirzada, Per Ladenvall, Per-Olof Hansson, Peter Eriksson, Mikael Dellborg Source Type: research
Case images: Malposition of an atrial pacemaker lead crossing through patent foramen ovale in a patient with ischemic stroke.
PMID: 26875138 [PubMed - as supplied by publisher]
Source: Turk Kardiyoloji Dernegi arsivi - January 1, 2016 Category: Cardiology Authors: Karavelioğlu Y, Doğan T, Kalçık M, Yalçınkaya A Tags: Turk Kardiyol Dern Ars Source Type: research
Economy Class Syndrome, patent foramen ovale and stroke
Whether or not air travel in a patient with patent foramen ovale (PFO) is a risk factor for cerebral embolism is unresolved. This is illustrated by a recent case report of the Massachusetts General Hospital in the New England Journal of Medicine of deep venous thrombosis and stroke associated with air travel. The discussant concluded that because of the relatively short flight “it seems unlikely that air travel was a major risk factor” 1. This may well be true for deep venous thrombosis per se, the risk of which has been shown to increase with duration of the flight 2.
Source: The American Journal of Cardiology - August 1, 2016 Category: Cardiology Authors: Franz H. Messerli, Stefano F. Rimoldi, Urs Scherrer Source Type: research
Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke
Publication date: October 2017 Source:Interventional Cardiology Clinics, Volume 6, Issue 4 Author(s): Olufunso W. Odunukan, Matthew J. PriceTeaser Approximately one-third of all strokes have no apparent cause. A patent foramen ovale (PFO) is present in as many as 60% of these patients with cryptogenic strokes, which is significantly more frequent than that of the general population. The presumed biologic mechanisms of ischemic stroke in the setting of a PFO are paradoxic embolism from the peripheral venous system through this interatrial shunt or embolism from in situ thrombosis. In this review, the authors summarize and ...
Source: Interventional Cardiology Clinics - September 6, 2017 Category: Cardiology Source Type: research
Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up
Little is known regarding changes in treatment effect over time associated with patent foramen ovale (PFO) closure among patients with embolic stroke of unknown origin.
Source: International Journal of Cardiology - January 3, 2018 Category: Cardiology Authors: Raffaele Piccolo, Anna Franzone, George C.M. Siontis, Stefan Stortecky, Thomas Pilgrim, Bernhard Meier, Stephan Windecker Tags: Short communication Source Type: research
Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample
Despite the widespread use of percutaneous closure of patent foramen ovale (PFO) in patients after a cryptogenic stroke, little is known about its impact on health-related quality of life (HRQoL). The aim of this study was to assess HRQoL in these patients compared to PFO patients not considered candidates for percutaneous closure, and to a normal population.
Source: International Journal of Cardiology - February 4, 2018 Category: Cardiology Authors: Naqibullah Mirzada, Per Ladenvall, Per-Olof Hansson, Peter Eriksson, Charles Taft, Mikael Dellborg Source Type: research
Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis
Patent foramen ovale (PFO) closure has emerged as a secondary prevention option in patients with PFO and cryptogenic stroke. However, the comparative efficacy and safety of percutaneous closure and medical the...
Source: BMC Cardiovascular Disorders - March 2, 2018 Category: Cardiology Authors: Xin-Lin Zhang, Li-Na Kang, Lian Wang and Biao Xu Tags: Research article Source Type: research
Patent foramen ovale after cryptogenic stroke: When is it justifiable to close it?
The incidence of patent foramen ovale (PFO) has been reported as high as 27% [1]. A strong association between cryptogenic stroke and PFO suggested that paradoxical embolism may be the culprit for such unexplained strokes. Several pathophysiological hypotheses have been proposed to explain paradoxical embolism: right ventricular dysfunction or decreased compliance, preferential flow from the inferior vena cava through the PFO, sometimes associated with an exuberant Eustachian valve or clot formation within an aneurysmal septum [2].
Source: International Journal of Cardiology - June 8, 2018 Category: Cardiology Authors: Alain Fraisse, Giovanni di Salvo, John C. Janssen, Sonya V. Babu-Narayan, Michael A. Gatzoulis Tags: Editorial Source Type: research
Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials
Controlled randomized trials (CRTs) comparing the efficacy of patent foramen ovale (PFO) closure and medical therapy in patients with cryptogenic stroke have yielded heterogeneous results. No data are available on the net clinical benefit with the two strategies.
Source: International Journal of Cardiology - June 8, 2018 Category: Cardiology Authors: Vincenzo Pasceri, Francesco Pelliccia, Edoardo Bressi, Ludmilla Mantione, Carlo Gaudio, Giulio Speciale, Roxana Mehran, George D. Dangas, Giuseppe Patti Source Type: research
Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials
Up to half the patients with cryptogenic stroke under the age of 55 years have been found to have a PFO. Observational studies have demonstrated a benefit from closure of PFO and several RCTs have shown a trend toward benefit. The cost and clinical effectiveness of PFO closure is unclear.
Source: International Journal of Cardiology - July 21, 2018 Category: Cardiology Authors: Christopher A. Pickett, Todd C. Villines, Jon R. Resar, Edward A. Hulten Source Type: research
Role of Echocardiography in Assessment of Cardioembolic Sources: a Strong Diagnostic Resource in Patients with Ischemic Stroke
AbstractPurpose of ReviewThis review will discuss the most frequent sources of cardiac embolism and the role of echocardiography in these different clinical settings, and, in addition, provide suggestions about the choice between transthoracic (TTE) and transesophageal echocardiography (TEE).Recent FindingsStroke is the third leading cause of death in industrial countries, and 15 –40% of all ischemic strokes are due to cardioembolism. TTE and TEE are cornerstones in the detection of cardioembolic sources and provide fundamental information about the embolic risk and most suitable treatment of these patients, improving lo...
Source: Current Cardiology Reports - October 11, 2018 Category: Cardiology Source Type: research
Stroke in patients with cardiovascular implantable electronic device infection undergoing transvenous lead removal
Stroke can be a devastating complication in patients with cardiovascular implantable electronic device (CIED) infection. Paradoxical septic embolism can occur in the presence of device leads and patent foramen ovale (PFO) via embolic dislodgment during transvenous lead removal (TLR).
Source: Heart Rhythm - October 30, 2018 Category: Cardiology Authors: Justin Z. Lee, Pradyumna Agasthi, Ahmed K. Pasha, Claudia Tarin, Andrew S. Tseng, Nancy N. Diehl, David O. Hodge, Christopher V. DeSimone, Ammar M. Killu, Peter A. Brady, Krishna Kancharla, Fred M. Kusumoto, Komandoor Srivathsan, Michael J. Osborn, Raul E Tags: Featured Article Source Type: research
Closure of patent foramen ovale and "cryptogenic" stroke: What's new, what's next?
PMID: 30792077 [PubMed - as supplied by publisher]
Source: Archives of Cardiovascular Diseases - February 18, 2019 Category: Cardiology Authors: Mas JL Tags: Arch Cardiovasc Dis Source Type: research
Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System
This study aimed to clarify the factors related to CS and to develop a score for high-risk PFO.
Source: Journal of the American Society of Echocardiography - May 22, 2019 Category: Cardiology Authors: Rie Nakayama, Yoichi Takaya, Teiji Akagi, Nobuhisa Watanabe, Madoka Ikeda, Koji Nakagawa, Norihisa Toh, Hiroshi Ito Source Type: research
